Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome: A case report

類似資料

• Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
  著者:: Barratt-Due, Andreas, 等
  出版事項: (2016)
• Clinical and Complement Long-Term Follow-Up of a Pediatric Patient with C3 Mutation-Related Atypical Hemolytic Uremic Syndrome
  著者:: Anna Bjerre, 等
  出版事項: (2018-01-01)
• Clinical and Complement Long-Term Follow-Up of a Pediatric Patient with C3 Mutation-Related Atypical Hemolytic Uremic Syndrome
  著者:: Bjerre, Anna, 等
  出版事項: (2018)
• Clinical and Complement Long-Term Follow-Up of a Pediatric Patient with C3 Mutation-Related Atypical Hemolytic Uremic Syndrome
  著者:: Anna Bjerre, 等
  出版事項: (2018-01-01)
• Eculizumab treatment efficiently prevents C5 cleavage without C5a generation in vivo
  著者:: Volokhina, Elena B., 等
  出版事項: (2015)